Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

methotrexate

An antimetabolite and antifolate agent with antineoplastic and immunosuppressant activities. Methotrexate binds to and inhibits the enzyme dihydrofolate reductase, resulting in inhibition of purine nucleotide and thymidylate synthesis and, subsequently, inhibition of DNA and RNA syntheses. Methotrexate also exhibits potent immunosuppressant activity although the mechanism(s) of actions is unclear.
Synonym:alpha-methopterin
amethopterin
methotrexate LPF
methotrexate methylaminopterin
methotrexatum
metotrexato
Rheumatrex
US brand name:Jylamvo
Foreign brand name:Brimexate
Emtexate
Emthexat
Emthexate
Farmitrexat
Fauldexato
Lantarel
Ledertrexate
Lumexon
Maxtrex
Medsatrexate
Metex
Methoblastin
Metrotex
Novatrex
Texate
Tremetex
Trexeron
Trixilem
Abbreviation:MTX
Code name:CL 14377
CL-14377
WR-19039
Chemical structure:4-amino-10-methylfolic acid
4-amino-4-deoxy-10-methylpteroyl-L-glutamic acid
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Search NCI's Drug Dictionary